Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
4.010
+0.130 (3.35%)
At close: Dec 9, 2025, 4:00 PM EST
4.010
0.00 (0.00%)
After-hours: Dec 9, 2025, 4:10 PM EST
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.81 million as of December 9, 2025. Its market cap has decreased by -36.33% in one year.
Market Cap
15.81M
Enterprise Value
-8.50M
1-Year Change
-36.33%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.81M, a decrease of -96.77%. That is a compound annual growth rate of -48.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 15.30M | -32.55% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |